Google News

CDSCO Approves AstraZeneca's Fasenra for Hypereosinophilic Syndrome in India - Medical Dialogues

Jul 18, 2026, 11:35 AM

Translate article text

Choose a language and wait for the translated text.

CDSCO Approves AstraZeneca's Fasenra for Hypereosinophilic Syndrome in India  Medical Dialogues